EDGAR Filing Documents for 0001193125-17-047926

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

SEC Accession No. 0001193125-17-047926

Filing Date

2017-02-17

Accepted

2017-02-17 15:58:55

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13D/A	d342241dsc13da.htm	SC 13D/A	36172
	Complete submission text file	0001193125-17-047926.txt		37571

Mailing Address 4-20-3 EBISU SHIBUYA-KU TOKYO M0 150-0013

Business Address 4-20-3 EBISU SHIBUYA-KU TOKYO M0 150-0013 81 3 5789-5872

KUBOTA PHARMACEUTICAL HOLDINGS CO LTD (Subject) CIK: 0001400482 (see all company filings)

IRS No.: 981295657 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88011 | Film No.: 17621297
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1301 SECOND AVE., SUITE 4200 SEATTLE WA 98101

Business Address

KUBOTA RYO (Filed by) CIK: 0001598575 (see all company filings)

Type: SC 13D/A